Lexicon Pharmaceuticals, Inc.
(NASDAQ : LXRX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen, Inc.
-2.83%273.901.4%$805.26m
AMGNAmgen, Inc.
-0.09%218.021.3%$494.55m
CELGCelgene Corp.
-0.45%109.911.3%$454.63m
GILDGilead Sciences, Inc.
0.58%63.701.0%$381.27m
ILMNIllumina, Inc.
0.03%298.303.5%$303.30m
VRTXVertex Pharmaceuticals, Inc.
-1.10%204.821.9%$296.48m
REGNRegeneron Pharmaceuticals, Inc.
-2.59%339.282.6%$257.77m
EXASEXACT Sciences Corp.
1.71%79.5924.0%$198.21m
ALXNAlexion Pharmaceuticals, Inc.
-1.17%105.882.0%$181.05m
SGENSeattle Genetics, Inc.
0.16%112.396.1%$131.76m
BMRNBioMarin Pharmaceutical, Inc.
-0.18%76.004.3%$116.03m
SRPTSarepta Therapeutics, Inc.
-2.75%98.2314.6%$112.26m
AAgilent Technologies, Inc.
-0.37%76.881.6%$100.74m
MRTXMirati Therapeutics, Inc.
1.26%102.002.3%$87.70m
NBIXNeurocrine Biosciences, Inc.
-0.79%110.035.0%$84.99m

Company Profile

Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. It drug candidates include XERMELO, Sotagliflozin, LX2761, and LX9211. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.